Mulberroside A is a glycosylated stilbene with demonstrated nephroprotective, hypoglycemic, and anti-diabetic properties. Its deglycosylation enhances anti-melanogenic activity, while its anti-inflammatory and anti-apoptotic effects are mediated through the suppression of key pro-inflammatory cytokines and signaling pathways such as NF-kappaB, MAPK, and the NLRP3 inflammasome.